A longitudinal study of Middle East respiratory syndrome coronavirus (MERS-CoV) in dromedary camels.


Journal

BMC veterinary research
ISSN: 1746-6148
Titre abrégé: BMC Vet Res
Pays: England
ID NLM: 101249759

Informations de publication

Date de publication:
02 Nov 2023
Historique:
received: 19 03 2022
accepted: 03 10 2023
medline: 6 11 2023
pubmed: 3 11 2023
entrez: 3 11 2023
Statut: epublish

Résumé

Middle East respiratory syndrome coronavirus (MERS-CoV) was identified in humans in 2012. Since then, 2605 cases and 937 associated deaths have been reported globally. Camels are the natural host for MERS-CoV and camel to human transmission has been documented. The relationship between MERS-CoV shedding and presence of neutralizing antibodies in camels is critical to inform surveillance and control, including future deployment of camel vaccines. However, it remains poorly understood. The longitudinal study conducted in a closed camel herd in Egypt between December 2019 and March 2020 helped to characterize the kinetics of MERS-CoV neutralizing antibodies and its relation with viral shedding. During the 100-day longitudinal study, 27 out of 54 camels (50%) consistently tested negative for presence of antibodies against MERS-CoV, 19 (35.2%) tested positive and 8 (14.8%) had both, positive and negative test results. Fourteen events that could be interpreted as serological indication of probable infection (two seroconversions and twelve instances of positive camels more than doubling their optical density ratio (OD ratio) in consecutive samples) were identified. Observed times between the identified events provided strong evidence (p = 0.002) against the null hypothesis that they occurred with constant rate during the study, as opposed to clustering at certain points in time. A generalized additive model showed that optical density ratio (OD ratio) is positively associated with being an adult and varies across individual camels and days, peaking at around days 20 and 90 of the study. Despite serological indication of probable virus circulation and intense repeated sampling, none of the tested nasal swab samples were positive for MERS-CoV RNA, suggesting that, if the identified serological responses are the result of virus circulation, the virus may be present in nasal tissue of infected camels during a very narrow time window. Longitudinal testing of a closed camel herd with past history of MERS-CoV infection is compatible with the virus continuing to circulate in the herd despite lack of contact with other camels. It is likely that episodes of MERS-CoV infection in camels can take place with minimal presence of the virus in their nasal tissues, which has important implications for future surveillance and control of MERS-CoV in camel herds and prevention of its zoonotic transmission.

Sections du résumé

BACKGROUND BACKGROUND
Middle East respiratory syndrome coronavirus (MERS-CoV) was identified in humans in 2012. Since then, 2605 cases and 937 associated deaths have been reported globally. Camels are the natural host for MERS-CoV and camel to human transmission has been documented. The relationship between MERS-CoV shedding and presence of neutralizing antibodies in camels is critical to inform surveillance and control, including future deployment of camel vaccines. However, it remains poorly understood. The longitudinal study conducted in a closed camel herd in Egypt between December 2019 and March 2020 helped to characterize the kinetics of MERS-CoV neutralizing antibodies and its relation with viral shedding.
RESULTS RESULTS
During the 100-day longitudinal study, 27 out of 54 camels (50%) consistently tested negative for presence of antibodies against MERS-CoV, 19 (35.2%) tested positive and 8 (14.8%) had both, positive and negative test results. Fourteen events that could be interpreted as serological indication of probable infection (two seroconversions and twelve instances of positive camels more than doubling their optical density ratio (OD ratio) in consecutive samples) were identified. Observed times between the identified events provided strong evidence (p = 0.002) against the null hypothesis that they occurred with constant rate during the study, as opposed to clustering at certain points in time. A generalized additive model showed that optical density ratio (OD ratio) is positively associated with being an adult and varies across individual camels and days, peaking at around days 20 and 90 of the study. Despite serological indication of probable virus circulation and intense repeated sampling, none of the tested nasal swab samples were positive for MERS-CoV RNA, suggesting that, if the identified serological responses are the result of virus circulation, the virus may be present in nasal tissue of infected camels during a very narrow time window.
CONCLUSIONS CONCLUSIONS
Longitudinal testing of a closed camel herd with past history of MERS-CoV infection is compatible with the virus continuing to circulate in the herd despite lack of contact with other camels. It is likely that episodes of MERS-CoV infection in camels can take place with minimal presence of the virus in their nasal tissues, which has important implications for future surveillance and control of MERS-CoV in camel herds and prevention of its zoonotic transmission.

Identifiants

pubmed: 37919680
doi: 10.1186/s12917-023-03769-z
pii: 10.1186/s12917-023-03769-z
pmc: PMC10621169
doi:

Substances chimiques

Antibodies, Neutralizing 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

228

Informations de copyright

© 2023. The Author(s).

Références

Emerg Infect Dis. 2014 Jun;20(6):1049-53
pubmed: 24856660
Heliyon. 2021 Oct 12;7(10):e08166
pubmed: 34703929
Front Med. 2016 Jun;10(2):120-36
pubmed: 26791756
Emerg Infect Dis. 2021 Jul;27(7):1964-1968
pubmed: 34152977
Vector Borne Zoonotic Dis. 2017 Feb;17(2):155-159
pubmed: 28009529
Lancet Infect Dis. 2004 Nov;4(11):704-8
pubmed: 15522683
Emerg Infect Dis. 2017 Mar;23(3):550-551
pubmed: 28221127
Epidemiol Infect. 2019 Jan;147:e84
pubmed: 30869000
Comp Clin Path. 2022;31(3):537-546
pubmed: 35506144
Emerg Infect Dis. 2021 Sep;27(9):2301-2311
pubmed: 34423762
Emerg Microbes Infect. 2017 Jan 4;6(1):e1
pubmed: 28050021
Euro Surveill. 2012 Dec 06;17(49):
pubmed: 23231891
Euro Surveill. 2013 Dec 12;18(50):20659
pubmed: 24342517
Emerg Infect Dis. 2014 Jun;20(6):1012-5
pubmed: 24857749
Euro Surveill. 2013 Sep 05;18(36):pii=20574
pubmed: 24079378
Emerg Microbes Infect. 2018 Nov 28;7(1):195
pubmed: 30482895
Lancet Infect Dis. 2013 Oct;13(10):859-66
pubmed: 23933067
Viruses. 2022 Aug 09;14(8):
pubmed: 36016365
Emerg Infect Dis. 2019 Dec;25(12):2333-2335
pubmed: 31742534
Viruses. 2019 Aug 05;11(8):
pubmed: 31387326
Vet Q. 2020 Dec;40(1):190-197
pubmed: 32543343
N Engl J Med. 2012 Nov 8;367(19):1814-20
pubmed: 23075143
Int J Epidemiol. 2020 Jun 1;49(3):717-726
pubmed: 32086938
Viruses. 2019 Mar 02;11(3):
pubmed: 30832356
Sci Rep. 2019 Nov 8;9(1):16292
pubmed: 31705137
Emerg Infect Dis. 2016 Dec;22(12):2171-2173
pubmed: 27224315
N Engl J Med. 2014 Jun 26;370(26):2499-505
pubmed: 24896817

Auteurs

Mohamed Abdelazim (M)

General Organization for Veterinary Service, Cairo, Egypt. m.abdelazim60@gmail.com.

Rehab Abdelkader (R)

General Organization for Veterinary Service, Cairo, Egypt.

Abdelhakim Ali (A)

General Organization for Veterinary Service, Cairo, Egypt.

Momtaz A Shahein (MA)

Agriculture Research Center, Animal Health Research Institute, Cairo, Egypt.

Zelalem Tadesse (Z)

Food and Agriculture Organizations of the United Nations (FAO), Cairo, Egypt.

Ahmed Saad (A)

Food and Agriculture Organizations of the United Nations (FAO), Cairo, Egypt.

Amal Mansour (A)

Food and Agriculture Organizations of the United Nations (FAO), Regional Office for the Middle East and North Africa, Cairo, Egypt.

Samah F Ali (SF)

Agriculture Research Center, Animal Health Research Institute, Cairo, Egypt.

Mohamed Atea (M)

General Organization for Veterinary Service, Cairo, Egypt.

Emma Gardner (E)

Food and Agriculture Organizations of the United Nations (FAO), Rome, Italy.

Sophie VonDobschuetz (S)

Food and Agriculture Organizations of the United Nations (FAO), Rome, Italy.

Subhash Morzaria (S)

Institute for Infectious Animal Diseases, Texas A & M University, College Station, USA.

Yilma Makonnen (Y)

Food and Agriculture Organizations of the United Nations (FAO), Sub-regional Office for Eastern Africa, Addis Ababa, Ethiopia.

Juan Lubroth (J)

Lubroth One Health Consultancies, Rome, Italy.

Keith Sumption (K)

Food and Agriculture Organizations of the United Nations (FAO), Rome, Italy.

Ihab ElMasry (I)

Food and Agriculture Organizations of the United Nations (FAO), Rome, Italy.

Tarek Zakaria (T)

General Organization for Veterinary Service, Cairo, Egypt.

Samah Eid (S)

Agriculture Research Center, Animal Health Research Institute, Cairo, Egypt.

Eman Abo Hatab (EA)

Agriculture Research Center, Animal Health Research Institute, Cairo, Egypt.

Naglaa M Hagag (NM)

Agriculture Research Center, Animal Health Research Institute, Cairo, Egypt.

Hend M Y Yousef (HMY)

General Organization for Veterinary Service, Cairo, Egypt.

Mervate Emara (M)

General Organization for Veterinary Service, Cairo, Egypt.

Dina A Abdelwahed (DA)

Agriculture Research Center, Animal Health Research Institute, Cairo, Egypt.

Hala K Abdelmegeed (HK)

Agriculture Research Center, Animal Health Research Institute, Cairo, Egypt.

Mervat E Hamdy (ME)

Agriculture Research Center, Animal Health Research Institute, Cairo, Egypt.

Othman N O Mansour (ONO)

Agriculture Research Center, Animal Health Research Institute, Cairo, Egypt.

Javier Guitian (J)

The Royal Veterinary College, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH